@ARTICLE{Tamadon, author = {Beigrezaei, Sara and Heidari, Maryam and Tamadon, Mohammad Reza and }, title = {Role of adiponectin in patients with end-stage renal failure}, volume = {19}, number = {3}, abstract ={Adiponectin is a cytokine produced by the adipose tissue. This collagen-like protein has 244-amino acid and its concentration in plasma of healthy individuals is 5-40 μg / mL. In fact, adiponectin comprises 1% of the total serum protein.  Although, adiponectin has anti-inflammatory and anti-atherogenic effects in physiological conditions and plays a key role in lipid and glucose metabolism and energy balance as well. However, in patients with end-stage renal disease, it is not a protector due to the changes in the structure and function, and also is considered as a risk factor. So with regard to the prevalence of atherosclerosis in patients with end stage renal disease, adiponectin may be a marker for indentifying the cardiovascular involvement of these patients. }, URL = {http://koomeshjournal.semums.ac.ir/article-1-3565-en.html}, eprint = {http://koomeshjournal.semums.ac.ir/article-1-3565-en.pdf}, journal = {Koomesh journal}, doi = {}, year = {1396} }